KCG
CLMT icon

Knight Capital Group’s Calumet Specialty Products CLMT Stock Holding History

Knight Capital Group’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$283K Buy
+7,795
New +$280K 0.01% 2307

Other funds holding CLMT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AM
Appaloosa Management Miami Beach, Florida $5.01B AUM 0.22% 1-Year Est. Return

Knight Capital Group's CLMT Position: Q2 2013 in Review

Knight Capital Group opened a new position in Calumet Specialty Products (CLMT) in Q2 2013: 7,795 shares worth $283K. The stake represents 0.01% of the portfolio and ranks #2307 among its holdings.

117 funds tracked by Wall St. Rank hold CLMT as of Q2 2013.

  • Knight Capital Group held 7,795 shares of Calumet Specialty Products worth $283K as of Q2 2013.
  • Calumet Specialty Products was a new Knight Capital Group position in Q2 2013.
  • Calumet Specialty Products made up 0.01% of Knight Capital Group's portfolio in Q2 2013, its #2307 holding.
  • 117 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.